Gemphire Therapeutics Inc (GEMP) Actualités

Current Report Filing (8-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549    ...

Current Report Filing (8-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...

Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals

ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc...

Unknown (sec Staff)

Unknown (sec Staff)

Current Report Filing (8-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...

Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals

ANN ARBOR, Mich., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) announced today...

Quarterly Report (10-q)

Table of Contents      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO GEMPHIRE FINANCIAL...

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO GEMPHIRE FINANCIAL...

Current Report Filing (8-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K...